Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Clinical Results for Teva’s Biologic Oncology Candidates Reported

FDAnews Drug Daily Bulletin

July 3, 2012 | Vol. 9 No. 130

Clinical Results for Teva’s Biologic Oncology Candidates Reported

Teva Pharmaceutical announced the presentation of clinical results for its biologic oncology candidates, lipegfilgrastim and balugrastim, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2012 International Symposium on Supportive Care in Cancer.
News-Medical

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Pharma Blog Watch Drug Prices to Increase By 10 Percent Enbrel and the Autoimmune Era India, Argentina Broaden Trade, Co-op Range

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.